vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and PEGASYSTEMS INC (PEGA). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $430.0M, roughly 1.1× PEGASYSTEMS INC). PEGASYSTEMS INC runs the higher net margin — 7.6% vs 6.8%, a 0.8% gap on every dollar of revenue. On growth, Pediatrix Medical Group, Inc. posted the faster year-over-year revenue change (-1.7% vs -9.6%). Over the past eight quarters, PEGASYSTEMS INC's revenue compounded faster (10.7% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
Pegasystems Inc. (Pega) is a global software company based in Waltham, Massachusetts, in the United States, and founded in 1983. The company has been publicly traded since 1996 as PEGA (NASDAQ). Pega is a low-code platform for workflow automation and generative AI-powered decision-making for businesses.
MD vs PEGA — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $430.0M |
| Net Profit | $33.7M | $32.8M |
| Gross Margin | — | 75.2% |
| Operating Margin | 9.9% | 8.6% |
| Net Margin | 6.8% | 7.6% |
| Revenue YoY | -1.7% | -9.6% |
| Net Profit YoY | 10.5% | -61.6% |
| EPS (diluted) | $0.40 | $0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $430.0M | ||
| Q4 25 | $493.8M | $504.3M | ||
| Q3 25 | $492.9M | $381.4M | ||
| Q2 25 | $468.8M | $384.5M | ||
| Q1 25 | $458.4M | $475.6M | ||
| Q4 24 | $502.4M | $490.8M | ||
| Q3 24 | $511.2M | $325.1M | ||
| Q2 24 | $504.3M | $351.2M |
| Q1 26 | — | $32.8M | ||
| Q4 25 | $33.7M | $234.6M | ||
| Q3 25 | $71.7M | $43.4M | ||
| Q2 25 | $39.3M | $30.1M | ||
| Q1 25 | $20.7M | $85.4M | ||
| Q4 24 | $30.5M | $119.1M | ||
| Q3 24 | $19.4M | $-14.4M | ||
| Q2 24 | $-153.0M | $6.6M |
| Q1 26 | — | 75.2% | ||
| Q4 25 | — | 79.5% | ||
| Q3 25 | — | 72.2% | ||
| Q2 25 | — | 71.5% | ||
| Q1 25 | — | 78.5% | ||
| Q4 24 | — | 79.1% | ||
| Q3 24 | — | 70.2% | ||
| Q2 24 | — | 72.4% |
| Q1 26 | — | 8.6% | ||
| Q4 25 | 9.9% | 20.7% | ||
| Q3 25 | 13.8% | 3.8% | ||
| Q2 25 | 12.8% | 4.5% | ||
| Q1 25 | 7.0% | 26.7% | ||
| Q4 24 | 7.8% | 29.1% | ||
| Q3 24 | 6.6% | -3.6% | ||
| Q2 24 | -31.3% | 3.7% |
| Q1 26 | — | 7.6% | ||
| Q4 25 | 6.8% | 46.5% | ||
| Q3 25 | 14.5% | 11.4% | ||
| Q2 25 | 8.4% | 7.8% | ||
| Q1 25 | 4.5% | 18.0% | ||
| Q4 24 | 6.1% | 24.3% | ||
| Q3 24 | 3.8% | -4.4% | ||
| Q2 24 | -30.3% | 1.9% |
| Q1 26 | — | $0.18 | ||
| Q4 25 | $0.40 | $0.81 | ||
| Q3 25 | $0.84 | $0.24 | ||
| Q2 25 | $0.46 | $0.17 | ||
| Q1 25 | $0.24 | $0.91 | ||
| Q4 24 | $0.37 | $1.35 | ||
| Q3 24 | $0.23 | $-0.17 | ||
| Q2 24 | $-1.84 | $0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $270.0M |
| Total DebtLower is stronger | $570.5M | — |
| Stockholders' EquityBook value | $865.9M | $705.9M |
| Total Assets | $2.2B | $1.6B |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $270.0M | ||
| Q4 25 | $375.2M | $425.8M | ||
| Q3 25 | $340.1M | $351.4M | ||
| Q2 25 | $224.7M | $411.6M | ||
| Q1 25 | $99.0M | $371.7M | ||
| Q4 24 | $229.9M | $740.0M | ||
| Q3 24 | $103.8M | $703.0M | ||
| Q2 24 | $19.4M | $665.1M |
| Q1 26 | — | — | ||
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $705.9M | ||
| Q4 25 | $865.9M | $787.4M | ||
| Q3 25 | $890.7M | $596.8M | ||
| Q2 25 | $833.8M | $624.5M | ||
| Q1 25 | $789.2M | $611.3M | ||
| Q4 24 | $764.9M | $585.5M | ||
| Q3 24 | $732.5M | $473.0M | ||
| Q2 24 | $706.5M | $435.4M |
| Q1 26 | — | $1.6B | ||
| Q4 25 | $2.2B | $1.6B | ||
| Q3 25 | $2.2B | $1.3B | ||
| Q2 25 | $2.1B | $1.3B | ||
| Q1 25 | $2.0B | $1.3B | ||
| Q4 24 | $2.2B | $1.8B | ||
| Q3 24 | $2.1B | $1.6B | ||
| Q2 24 | $2.0B | $1.5B |
| Q1 26 | — | — | ||
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | — |
| Free Cash FlowOCF − Capex | — | $206.5M |
| FCF MarginFCF / Revenue | — | 48.0% |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 3.39× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $494.9M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $114.1M | $158.4M | ||
| Q3 25 | $137.3M | $56.3M | ||
| Q2 25 | $137.2M | $86.3M | ||
| Q1 25 | $-117.5M | $204.2M | ||
| Q4 24 | $133.0M | $95.2M | ||
| Q3 24 | $91.8M | $30.5M | ||
| Q2 24 | $107.0M | $40.1M |
| Q1 26 | — | $206.5M | ||
| Q4 25 | — | $152.4M | ||
| Q3 25 | — | $51.8M | ||
| Q2 25 | — | $84.1M | ||
| Q1 25 | — | $202.3M | ||
| Q4 24 | — | $92.4M | ||
| Q3 24 | — | $27.4M | ||
| Q2 24 | — | $38.8M |
| Q1 26 | — | 48.0% | ||
| Q4 25 | — | 30.2% | ||
| Q3 25 | — | 13.6% | ||
| Q2 25 | — | 21.9% | ||
| Q1 25 | — | 42.5% | ||
| Q4 24 | — | 18.8% | ||
| Q3 24 | — | 8.4% | ||
| Q2 24 | — | 11.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.2% | ||
| Q3 25 | — | 1.2% | ||
| Q2 25 | — | 0.6% | ||
| Q1 25 | — | 0.4% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | — | 0.9% | ||
| Q2 24 | — | 0.4% |
| Q1 26 | — | — | ||
| Q4 25 | 3.39× | 0.68× | ||
| Q3 25 | 1.91× | 1.30× | ||
| Q2 25 | 3.49× | 2.87× | ||
| Q1 25 | -5.66× | 2.39× | ||
| Q4 24 | 4.36× | 0.80× | ||
| Q3 24 | 4.72× | — | ||
| Q2 24 | — | 6.06× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
PEGA
| Pega Cloud | $205.0M | 48% |
| Subscription license | $94.9M | 22% |
| Maintenance | $75.3M | 18% |
| Consulting | $54.8M | 13% |
